ERBB2 and breast carcinoma: This breast cancer GEMM has very short latency (tumors were detected within a week of inducing the oncogene and almost all mice developed tumors within a month (Zhang et al, 2021b)) and green fluorescent protein was co-induced with an inducible constituently active Her2 oncogene.